Literature DB >> 19768416

Animal models for evaluation of influenza vaccines.

Ralph A Tripp1, S Mark Tompkins.   

Abstract

Influenza viruses are emerging and re-emerging viruses that cause worldwide epidemics and pandemics. Despite substantial knowledge of the mechanisms of infection and immunity, only modest progress has been made in human influenza vaccine development. The rational basis for influenza vaccine development originates in animal models that have helped us to understand influenza species barriers, virus-host interactions, factors that affect transmission, disease pathogenesis, and disease intervention strategies. As influenza evolution can surmount species barriers and disease intervention strategies that include vaccines, our need for appropriate animal models and potentially new host species will evolve to meet these adaptive challenges. This chapter discusses animal models for evaluating vaccines and discusses the challenges and strengths of these models.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19768416     DOI: 10.1007/978-3-540-92165-3_19

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  21 in total

Review 1.  Animal models for influenza virus transmission studies: a historical perspective.

Authors:  Nicole M Bouvier
Journal:  Curr Opin Virol       Date:  2015-06-28       Impact factor: 7.090

Review 2.  Fast vaccine design and development based on correlates of protection (COPs).

Authors:  Cécile van Els; Siri Mjaaland; Lisbeth Næss; Julia Sarkadi; Eva Gonczol; Karen Smith Korsholm; Jon Hansen; Jørgen de Jonge; Gideon Kersten; Jennifer Warner; Amanda Semper; Corine Kruiswijk; Fredrik Oftung
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

3.  Delta inulin polysaccharide adjuvant enhances the ability of split-virion H5N1 vaccine to protect against lethal challenge in ferrets.

Authors:  R Colby Layton; Nikolai Petrovsky; Andrew P Gigliotti; Zemmie Pollock; Jennifer Knight; Nathaniel Donart; John Pyles; Kevin S Harrod; Peng Gao; Frederick Koster
Journal:  Vaccine       Date:  2011-07-06       Impact factor: 3.641

Review 4.  Influenza, immune system, and pregnancy.

Authors:  Renju S Raj; Elizabeth A Bonney; Mark Phillippe
Journal:  Reprod Sci       Date:  2014-06-04       Impact factor: 3.060

5.  Aerosol inoculation with a sub-lethal influenza virus leads to exacerbated morbidity and pulmonary disease pathogenesis.

Authors:  Jennifer Humberd Smith; Tamas Nagy; Jamie Barber; Paula Brooks; S Mark Tompkins; Ralph A Tripp
Journal:  Viral Immunol       Date:  2011-04       Impact factor: 2.257

6.  Elicitation of Protective Antibodies against 20 Years of Future H3N2 Cocirculating Influenza Virus Variants in Ferrets Preimmune to Historical H3N2 Influenza Viruses.

Authors:  James D Allen; Hyesun Jang; Joshua DiNapoli; Harold Kleanthous; Ted M Ross
Journal:  J Virol       Date:  2019-01-17       Impact factor: 5.103

7.  Comprehensive analysis of N-glycans in IgG purified from ferrets with or without influenza A virus infection.

Authors:  Guozhang Zou; Martina Kosikova; Su-Ryun Kim; Shweta Kotian; Wells W Wu; Rongfong Shen; David N Powers; Cyrus Agarabi; Hang Xie; Tongzhong Ju
Journal:  J Biol Chem       Date:  2018-10-12       Impact factor: 5.157

8.  Response of BALB/c mice to a monovalent influenza A (H1N1) 2009 split vaccine.

Authors:  Penghui Yang; Li Xing; Chong Tang; Weihong Jia; Zhongpeng Zhao; Kun Liu; Xiao Gao; Xiliang Wang
Journal:  Cell Mol Immunol       Date:  2010-02-01       Impact factor: 11.530

Review 9.  Molecular determinants of influenza virus pathogenesis in mice.

Authors:  Ram P Kamal; Jaqueline M Katz; Ian A York
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

10.  Elicitation of Protective Antibodies against a Broad Panel of H1N1 Viruses in Ferrets Preimmune to Historical H1N1 Influenza Viruses.

Authors:  Donald M Carter; Christopher A Darby; Scott K Johnson; Michael A Carlock; Greg A Kirchenbaum; James D Allen; Thorsten U Vogel; Simon Delagrave; Joshua DiNapoli; Harold Kleanthous; Ted M Ross
Journal:  J Virol       Date:  2017-11-30       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.